Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.

Chkheidze R, Cimino PJ, Hatanpaa KJ, White CL, Ferreira M, Piccirillo SGM, Li L, Rajaram S, Nyagilo JO, Burns DK, Raisanen JM, Cai C.

J Neuropathol Exp Neurol. 2019 Sep 12. pii: nlz091. doi: 10.1093/jnen/nlz091. [Epub ahead of print]

PMID:
31589317
2.

Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.

Richardson TE, Patel S, Serrano J, Sathe AA, Daoud EV, Oliver D, Maher EA, Madrigales A, Mickey BE, Taxter T, Jour G, White CL, Raisanen JM, Xing C, Snuderl M, Hatanpaa KJ.

J Neuropathol Exp Neurol. 2019 Jun 1;78(6):501-507. doi: 10.1093/jnen/nlz025.

PMID:
31034050
3.

Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.

Lehman NL, Usubalieva A, Lin T, Allen SJ, Tran QT, Mobley BC, McLendon RE, Schniederjan MJ, Georgescu MM, Couce M, Dulai MS, Raisanen JM, Al Abbadi M, Palmer CA, Hattab EM, Orr BA.

Acta Neuropathol Commun. 2019 Mar 15;7(1):42. doi: 10.1186/s40478-019-0689-3.

4.

H3 K27M Mutations in Thalamic Pilocytic Astrocytomas with Anaplasia.

El Ahmadieh TY, Plitt A, Kafka B, Aoun SG, Raisanen JM, Orr B, Pan E, Wardak Z, Nedzi LA, Patel TR.

World Neurosurg. 2019 Jan 10. pii: S1878-8750(19)30015-4. doi: 10.1016/j.wneu.2018.12.147. [Epub ahead of print]

PMID:
30639498
5.

Successful Novel Treatment of a Paraspinal Primitive Neuroectodermal Tumor with Predominantly Glial Differentiation: A 3-Year Follow-Up After Surgery, Intensity-Modulated Radiation Therapy and Oral Temozolomide.

El Ahmadieh TY, Raisanen JM, Botros J, Kabangu JL, Pan E, Gluf W.

World Neurosurg. 2018 Nov;119:340-344. doi: 10.1016/j.wneu.2018.07.221. Epub 2018 Aug 1.

PMID:
30077020
6.

BRAF mutation leading to central nervous system rosai-dorfman disease.

Richardson TE, Wachsmann M, Oliver D, Abedin Z, Ye D, Burns DK, Raisanen JM, Greenberg BM, Hatanpaa KJ.

Ann Neurol. 2018 Jul;84(1):147-152. doi: 10.1002/ana.25281. Epub 2018 Aug 16.

PMID:
30014527
7.

Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry.

Georgescu MM, Olar A, Mobley BC, Faust PL, Raisanen JM.

Oncotarget. 2018 Jun 19;9(47):28652-28665. doi: 10.18632/oncotarget.25595. eCollection 2018 Jun 19.

8.

Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration.

Bao L, Chen Y, Lai HT, Wu SY, Wang JE, Hatanpaa KJ, Raisanen JM, Fontenot M, Lega B, Chiang CM, Semenza GL, Wang Y, Luo W.

Nucleic Acids Res. 2018 Jul 27;46(13):6576-6591. doi: 10.1093/nar/gky449.

9.

Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.

Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM, White CL 3rd, Foong C, Mickey BE, Pan E, Hatanpaa KJ.

J Neuropathol Exp Neurol. 2018 Apr 1;77(4):302-311. doi: 10.1093/jnen/nly006.

PMID:
29444279
10.

Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.

Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, Reis GF, Nobusawa S, Arita K, Felsberg J, Reifenberger G, Agaimy A, Buslei R, Capper D, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Paulus W, Kool M, Hasselblatt M.

Am J Surg Pathol. 2018 Apr;42(4):506-511. doi: 10.1097/PAS.0000000000001023.

PMID:
29324471
11.

Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis.

Richardson TE, Shen ZJ, Kanchwala M, Xing C, Filatenkov A, Shang P, Barnett S, Abedin Z, Malter JS, Raisanen JM, Burns DK, White CL, Hatanpaa KJ.

J Neuropathol Exp Neurol. 2017 Oct 1;76(10):874-882. doi: 10.1093/jnen/nlx072.

PMID:
28922848
12.

Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.

Richardson TE, Snuderl M, Serrano J, Karajannis MA, Heguy A, Oliver D, Raisanen JM, Maher EA, Pan E, Barnett S, Cai C, Habib AA, Bachoo RM, Hatanpaa KJ.

J Neurooncol. 2017 May;133(1):183-192. doi: 10.1007/s11060-017-2431-y. Epub 2017 Apr 18.

PMID:
28421459
13.

Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.

Choi C, Raisanen JM, Ganji SK, Zhang S, McNeil SS, An Z, Madan A, Hatanpaa KJ, Vemireddy V, Sheppard CA, Oliver D, Hulsey KM, Tiwari V, Mashimo T, Battiste J, Barnett S, Madden CJ, Patel TR, Pan E, Malloy CR, Mickey BE, Bachoo RM, Maher EA.

J Clin Oncol. 2016 Nov 20;34(33):4030-4039. doi: 10.1200/JCO.2016.67.1222. Epub 2016 Oct 31.

14.

Unusual skull tumors with psammomatoid bodies: a diagnostic challenge.

Richardson TE, Georgescu MM, Kapur P, Hwang H, Barnett SL, Raisanen JM, Cai C, Hatanpaa KJ.

Clin Neuropathol. 2017 May/Jun;36 (2017)(3):114-120. doi: 10.5414/NP300997. Review.

PMID:
28128725
15.

Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.

Lehman NL, Hattab EM, Mobley BC, Usubalieva A, Schniederjan MJ, McLendon RE, Paulus W, Rushing EJ, Georgescu MM, Couce M, Dulai MS, Cohen ML, Pierson CR, Raisanen JM, Martin SE, Lehman TD, Lipp ES, Bonnin JM, Al-Abbadi MA, Kenworthy K, Zhao K, Mohamed N, Zhang G, Zhao W.

Neuro Oncol. 2017 Jan;19(1):31-42. doi: 10.1093/neuonc/now118. Epub 2016 Jul 14.

16.

NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.

Georgescu MM, Mobley BC, Orr BA, Shang P, Lehman NL, Zhu X, O'Neill TJ, Rajaram V, Hatanpaa KJ, Timmons CF, Raisanen JM.

Acta Neuropathol Commun. 2016 May 27;4(1):55. doi: 10.1186/s40478-016-0329-0.

17.

The defining pathology of the new clinical and histopathologic entity ACTA2-related cerebrovascular disease.

Georgescu MM, Pinho Mda C, Richardson TE, Torrealba J, Buja LM, Milewicz DM, Raisanen JM, Burns DK.

Acta Neuropathol Commun. 2015 Dec 4;3:81. doi: 10.1186/s40478-015-0262-7.

18.

Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry.

Richardson TE, Mathis DA, Mickey BE, Raisanen JM, Burns DK, White CL 3rd, Hatanpaa KJ.

J Neuropathol Exp Neurol. 2015 Dec;74(12):1170-7. doi: 10.1097/NEN.0000000000000265.

PMID:
26574671
19.

Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.

Alcantara Llaguno SR, Wang Z, Sun D, Chen J, Xu J, Kim E, Hatanpaa KJ, Raisanen JM, Burns DK, Johnson JE, Parada LF.

Cancer Cell. 2015 Oct 12;28(4):429-440. doi: 10.1016/j.ccell.2015.09.007.

20.

NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.

Georgescu MM, Yell P, Mobley BC, Shang P, Georgescu T, Wang SH, Canoll P, Hatanpaa KJ, White CL 3rd, Raisanen JM.

Acta Neuropathol Commun. 2015 Mar 8;3:11. doi: 10.1186/s40478-015-0197-z.

21.

High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.

Hatanpaa KJ, Hu T, Vemireddy V, Foong C, Raisanen JM, Oliver D, Hiemenz MC, Burns DK, White CL 3rd, Whitworth LA, Mickey B, Stegner M, Habib AA, Fink K, Maher EA, Bachoo RM.

J Neurooncol. 2014 Mar;117(1):183-189. doi: 10.1007/s11060-014-1376-7. Epub 2014 Feb 12.

22.

Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Hatanpaa KJ, Raisanen JM, Herndon E, Burns DK, Foong C, Habib AA, White CL 3rd.

J Neuropathol Exp Neurol. 2014 Feb;73(2):136-42. doi: 10.1097/OPX.0000000000000170.

23.

Functional müllerian tissue within the conus medullaris generating cyclical neurological morbidity in an otherwise healthy female.

Scott WW, Ray B, Rickert KL, Madden CJ, Raisanen JM, Mendelsohn D, Rogers D, Whitworth TA.

Childs Nerv Syst. 2014 Apr;30(4):717-21. doi: 10.1007/s00381-013-2291-5. Epub 2013 Oct 1.

PMID:
24081711
24.

Non-pituitary origin sellar tumours mimicking pituitary macroadenomas.

Abele TA, Yetkin ZF, Raisanen JM, Mickey BE, Mendelsohn DB.

Clin Radiol. 2012 Aug;67(8):821-7. doi: 10.1016/j.crad.2012.01.001. Review.

PMID:
22749386
25.

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.

Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, Yang XL, Mashimo T, Raisanen JM, Marin-Valencia I, Pascual JM, Madden CJ, Mickey BE, Malloy CR, Bachoo RM, Maher EA.

Nat Med. 2012 Jan 26;18(4):624-9. doi: 10.1038/nm.2682.

26.

Exercise-associated numbness and tingling in the legs.

Sharp L, Pride L, Mathis D, Raisanen JM, Vernino S.

Arch Neurol. 2011 Dec;68(12):1599-602. doi: 10.1001/archneurol.2011.1195.

PMID:
22159060
27.

Infected giant ophthalmic artery aneurysm remnant following craniotomy for surgical clip ligation. Case report.

Haque A, Raisanen JM, Barnett SL, Samson DS.

J Neurosurg. 2010 Oct;113(4):786-9. doi: 10.3171/2010.3.JNS091892.

PMID:
20345224
28.

The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.

Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA.

Cancer Res. 2009 Apr 1;69(7):2809-16. doi: 10.1158/0008-5472.CAN-08-4079.

29.

Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.

Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA.

Cancer Res. 2006 Jan 15;66(2):867-74.

30.

Congenital brain tumors.

Raisanen JM, Davis RL.

Pathology (Phila). 1993;2(1):103-16. Review.

PMID:
9420933

Supplemental Content

Loading ...
Support Center